(2018) SD1000: 96.4 SVR12 in 1237 patients with hepatitis C genotypes 1, 2, 3, 4 using co-formulated sofosbuvir/daclatasvir tablets manufactured in Iran - a multicenter phase 3 clinical trial including HIV co-infected, transplant, and hemodialysis patients. Journal of Viral Hepatitis. pp. 198-199. ISSN 1352-0504
Full text not available from this repository.
Official URL: http://apps.webofknowledge.com/InboundService.do?F...
| Item Type: | Article |
|---|---|
| Keywords: | Gastroenterology & Hepatology Infectious Diseases Virology |
| Divisions: | |
| Page Range: | pp. 198-199 |
| Journal or Publication Title: | Journal of Viral Hepatitis |
| Journal Index: | ISI |
| Volume: | 25 |
| ISSN: | 1352-0504 |
| Depositing User: | مهندس مهدی شریفی |
| URI: | http://eprints.mubam.ac.ir/id/eprint/1296 |
Actions (login required)
 |
View Item |